Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Disease and Transplantation, Liver Disease Diagnosis and Treatment, Organ Transplantation Techniques and Outcomes, and Hepatocellular Carcinoma Treatment and Prognosis.
Refining the Baveno VII criteria for clinically significant portal hypertension: An individual patient data meta-analysis
Post-Banding Ulcer Bleeding After Endoscopic Ligation: Incidence, Risk Factors and Outcomes in Patients With Cirrhosis.
Carvedilol decreases hepatic vascular resistance by reducing fibrogenesis and reversing endothelial dysfunction in cirrhotic rats.
Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: A post hoc analysis of the PREDESCI trial.
Transjugular diagnostic procedures in hepatology: Indications, techniques and interpretation
Transjugular diagnostic procedures in hepatology: Indications, techniques and interpretation
Preventing the progression of cirrhosis to decompensation and death.
Statins for MAFLD/MASH: another brick in the wall while waiting for final answers.
Point-of-care ultrasound of the inferior vena cava for intravascular volume assessment during intravenous albumin infusion in patients with cirrhosis.
AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis.
Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysis.
Predicting survival in patients with 'non-high-risk' acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding.
Metabolic phenotyping of patients with advanced chronic liver disease for better characterization of cirrhosis regression.
Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant data.
Combination of Model for End-Stage Liver Disease (MELD) and Sarcopenia predicts mortality after transjugular intrahepatic portosystemic shunt (TIPS).
Hepatic Venous Pressure Gradient: Measurement and Pitfalls.
Endoscopic diagnosis and treatment for portal hypertension: not yet ready for clinical practice!
Role of calcium integrin-binding protein 1 in the mechanobiology of the liver endothelium.
TIPS for Portal Hypertension in HCC With Tumour Invasion of the Portal Vein Trunk: Anecdote or Promise?
Reply to: "5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial. Was an accurate statistical analysis performed?"
AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis.
Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding.
Mechanobiology of portal hypertension.
Incidence and factors predictive of recurrent thrombosis in people with non-cirrhotic portal vein thrombosis.
Increased sinusoidal pressure impairs liver endothelial mechanosensing, uncovering novel biomarkers of portal hypertension.
Predicting survival in patients with ‘non-high-risk’ acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding
Emerging Therapeutic Targets for Portal Hypertension.
Pre-emptive TIPS for the treatment of bleeding from gastric fundal varices: Results of a randomised controlled trial.
Quantifying the benefit of nonselective beta-blockers in the prevention of hepatic decompensation: A Bayesian reanalysis of the PREDESCI trial.